LECTURE 23 - diabetes Flashcards

1
Q

What is diabetes?

A
  • disease of dysregulated glucose control
  • a disease of high glucose (and BP and lipids)
  • caused by insufficient Acton of the hormone insulin
  • common
  • associated with significant morbidity
  • expensive to treat
  • part of the metabolic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is diabetes classified?

A
  • Type 1 (single gene mutations of endocrine pancreas or function of endocrine pancreas, defects of mitochondria  )
  • Type 2 (you can generate glucose intolerance during pregnancy - tends to go away after pregnancy but is usually a signal for getting type2 later in life)
  • monogenic diabetes - maturity-onset diabetes of the young (MODY), mitochondrial diabetes, neonatal diabetes
  • other - gestational diabetes, drug-induced, endrocrinopathies, secondary diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is type 1 diabetes?

A
  • insulin dependent diabetes, juvenile-onset
  • 0.3% of British population
  • dramatic onset
  • production of ketones
    • not enough insulin to bring glucose into cells to use as energy so breaks down fat instead as an energy source 
    • the liver converts fatty acids into ketones and these ketones are released into the blood stream to be used as energy 
    • these ketones are very acidic - can lead to ketoacidosis 

Cause: insulitis (disease of pancreases caused by infiltration of lymphocytes), autoimmune destruction of pancreatic beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is type 2 diabetes?

A
  • non insulin dependent, maturity-onset
  • insulin resistance
  • relative insulin deficiency
  • 8% of British pop.
  • no ketones
  • associated with obesity
  • metabolic syndrome consists of 2 things: type 2 diabetes and cardiovascular disease
    • increased in adipose tissue and the associated problems - adipocyte malfunction, insulin resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is metabolic syndrome?

A
  • has 2 components: type 2 diabetes and cardiovascular disease
  • caused by genetics, changes in diet, inactivity and obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do the components of metabolic syndrome alter?

A
  • altered energy homeostasis
  • AMP activated protein kinase involved in regulation of energy homeostasis
  • it phosphorylates and alters function of proteins
  • regulated by AMP levels, malfunction affects energy homeostasis. affected by excessive so this stimulates AMP kinase
  • metformin acts on AMP activated kinase to lower blood sugar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the symptoms of diabetes?

A
  • weight loss
  • extreme fatigue
  • prone to infections
  • osmotic symptoms (polyuria, thirst, blurred vision)
  • slow healing wounds
  • tingling pain or numbness in the hands/feet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is diabetes diagnosed?

A
  • measure urine glucose
  • measure blood glucose
    • random: blood taken as they are with finger prick. >11.1mM
    • fasting: asked to fast.>7.0mM
  • oral glucose tolerance test
    • asked to fast, blood taken, given a high sugar drink and then wait 2 hours to and measure blood glucose over 2 hours to see how fast glucose removed from body, speed at which glucose is cleared gives indication of diabetes
  • HbA1c test: measures blood glucose over past 2-3 months, used instead of fasting sugar measurements (haemoglobin becomes glycated if there’s lots of glucose in blood stream 
    Increase in presence of glycated haemoglobin the higher the fasting sugar )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathology that causes diabetes?

A
  • insulin resistance

- insulin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does insulin do to carbohydrate metabolism?

A
  • ↑ rate of glucose transport across the cell membrane in muscle and adipose tissue
  • ↑ the rate of glycolysis in muscle and adipose tissue
  • stimulates the rare of glycogen synthesis in adipose, muscle & liver
  • ↓ the rate of glycogen breakdown in muscle and liver
  • inhibits the rate of glycogenolysis and gluconeogenesis in the liver
  • ↑ the rate of glucose oxidation in the liver and adipose

–> overall effect of insulin is to ↓ breakdown of stored fuel and build with what is around

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does insulin do to fat metabolism?

A
  • inhibits rate of lipolysis in adipose
  • stimulates fatty acid and triacglycerol synthesis sin adipose and liver
  • ↑ VLDL formation in liver
  • ↑ lipoprotein lipase activity in adipose tissue; ↑ uptake of triglycerides from blood
  • ↓ rate of fatty acid oxidation in liver
  • ↑ rate of cholesterolgenesis in liver

–> overall effect is to inhibit lipolysis and therefore decrease release of fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where is insulin made?

A

Beta cells of Islets of Langerhans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is insulin released?

A
  • released in response to elevated [glucose]
  • glucose enters by GLUT2 and is metabolised and phosphorylated –> ↑ ATP production
  • ATP binds to K+ATP channel and plasma membrane
  • binding –> closure of K+ATP –> membrane depolarisation and opening of L type Ca+ channels
  • influx of Ca2+ = mobilisation of insulin containing vesicles –> exocytosis of insulin which causes cascade of events e.g. PI3 kinase -
    activation of insulin gene expression 
  • Ca increases in the cell when glucose increases in the cell 
  • Ca can be measured to measure the activity of beta cells 
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens to cell calcium in response to glucose?

A
  • can track [Ca2+] in beta cells from low (0.5mM) to high (11mM) of glucose
  • at low, some small oscillations, some small peaks
  • dramatically increased in response to glucose, this leads to release of insulin
  • mechanisms that lead to change in calcium are important to know to enable targeting with drugs
  • cell calcium spikes when cells is presented with high glucose - stays high until glucose is washed away
  • circadian control of insulin, more able to release it during the day than at night
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can we treat Type 1 diabetes?

A
  • lifestyle (eat healthily and regularly)
  • insulin injections (due to lack of insulin). Capillary blood glucose testing and insulin administration, glucometer measure blood glucose to tell you how much insulin to inject
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can we treat Type 2 diabetes?

A
  • lifestyle modifications (first line treatment)
  • reduce insulin resistance (e.g. exercise, drugs like metformin that mimic effects of exercise)
  • increase inulin secretion (drugs to target pathways that regulate insulin release)
  • insulin injection (when all else fails)
  • incretins
  • bariatric surgery? - changes believed to be associated with incretins
17
Q

What are incretins?

A
  • peptides released by gut normally
  • act to enhance function of beta cells
  • in presence of glucose, incretins able to increase amount of insulin secreted
  • this happens normally in the body but there are a range of mimetics that can mimic the effects
    +ve: effective, avoid hypoglycemic episodes as only work in presence of glucose, other beneficial effects such as satiety (make you feel full)
18
Q

What is metformin?

A
  • drug used to treat Type 2
  • first line treatment
  • ‘insulin sensitiser’
  • +ve: no hypoglycaemia, weight loss
  • -ve: nausea + GI effects, lactic acidosis, caution in kidney disease
19
Q

How does metformin work?

A
  • blocks gluconeogenesis by liver
  • ↑ glucose uptake by muscles
  • via action of AMP kinase
  • AMPK in liver, skeletal muscle + brain
  • also lipid-lowering effects within liver
20
Q

What are sulphonylureas?

A
  • e.g. Gliclazide
  • stimulates insulin release form beta cells
  • +ve: quick onset of action, effective at lowering glucose in early T2DM
  • -ve: hypoglycaemia, weight gain
  • not effective in later T2DM where beta cell function ceased
  • works on KATP channel by closing them, encouraging insulin release from beta cells
21
Q

What are thiazolidineadiones?

A
  • e.g. glitazone
  • work on lowering insulin resistance and improving insulin sensibility
  • make body produce new fat cells that are more sensitive to insulin (to then lower blood glucose)
  • involves activation of the gamma isoform of the peroxisome proliferator-activated receptor (PPAR gamma), a nuclear receptor. TZD-induced activation of PPAR gamma alters the transcription of several genes involved in glucose and lipid metabolism and energy balance, including those that code for lipoprotein lipase, fatty acid transporter protein, adipocyte fatty acid binding protein, fatty acyl-CoA synthase, malic enzyme, glucokinase and the GLUT4 glucose transporter. TZDs reduce insulin resistance in adipose tissue, muscle and the liver 
22
Q

What are SGLT2 inhibitors?

A
  • sodium-glucose cotransporter 2 inhibitors
  • inhibit glucose reabsorption in the proximal renal tubule
  • kidney filters 180g glucose per day, almost all reabsorbed
  • aim to reduce the amount of glucose being absorbed in the kidneys so that it is passed out in the urine
  • Phlorizin = naturally occurring SGLT2 inhibitor
23
Q

What are incretin-based therapies?

A
  • Glucagon-like peptide 1 (GLP-1) and GIP (glucose dependent insulinotrophic polypeptide
  • hormones released during food ingestion from L cells in ileum and colon and K cells in duodenum
  • stimulate glucose-dependent insulin secretion
  • incretin based medicines available in 2 families of medicines: DPP-4 Inhibitors and GLP-1 analogs
24
Q

What are the complications of diabetes?

A
  • large cost
  • diabetic retinopathy
  • diabetic neuropathy
  • limb amputation
  • kidney failure
  • heart disease and stroke
25
Q

What can be done to minimise the risk of complications?

A
  • education: self-monitoring, self-management, diet
  • aim for tight glycaemic control
  • BP control: antihypertensives
  • lipid profile: statins
  • annual review: retinal screening, urinary albumin excretion, foot care